Back to LGND Stock Lookup

Ligand Pharma (LGND) –

Sep 9, 2014 03:33 PM Roth Keeps Ligand (LGND) at 'Buy' Following New Captisol-Based Tech Launch
Sep 9, 2014 08:37 AM Ligand Pharma (LGND) Reports Expanded License Agreement with CURx Pharma
Sep 9, 2014 08:30 AM Ligand Licenses Captisol-enabled™ Lamotrigine to CURx Pharmaceuticals, Inc.
Sep 5, 2014 09:03 AM Lemelson Capital Management Marks Flagship Fund's Second Anniversary
Aug 28, 2014 11:11 AM Interferon Therapy for HCV Still Expected Strong Amid Daklinza Approval - Roth (LGND) (BMY)
Aug 27, 2014 09:26 AM Roth Comments on Ligand (LGND) Following Approval of Promact sNDA (GSK)
Aug 27, 2014 08:46 AM Ligand Pharma (LGND) Reports FDA Approval of Promacta/Revolade sNDA
Aug 27, 2014 08:00 AM Ligand Partner GlaxoSmithKline Receives U.S. FDA Approval for Promacta®/Revolade™ For Use in Patients with Severe Aplastic Anemia
Aug 25, 2014 11:48 AM Lemelson Capital Comments on Ligand Pharmaceuticals (LGND) Going Concern Risk
Aug 25, 2014 11:43 AM Lemelson Capital Comments on Large Institutional Selling in Shares of Ligand Pharmaceuticals Amidst Company's Insolvency and Mounting Going Concern Risk
Aug 21, 2014 05:13 PM Form SC 13G/A LIGAND PHARMACEUTICALS Filed by: BIOTECHNOLOGY VALUE FUND L P
Aug 18, 2014 05:17 PM Form 8-K LIGAND PHARMACEUTICALS For: Aug 12
Aug 15, 2014 02:52 PM Form 4 LIGAND PHARMACEUTICALS For: Aug 15 Filed by: HIGGINS JOHN L
Aug 15, 2014 09:30 AM Avion Pharmaceuticals, LLC, signs Captisol® License Agreement with Ligand Pharmaceuticals to develop four new products
Aug 14, 2014 10:57 AM Roth Remains Positive on Ligand Pharma (LNGD) Following New Licensing Agreement with Avion Pharma
Aug 14, 2014 09:15 AM Lemelson Capital Says Ligand Pharmaceuticals' $225M Debt Issuance Solidifies Company's Insolvency, Substantially Raises Specter of Bankruptcy
Aug 14, 2014 08:01 AM Ligand Pharma (LGND), Avion Pharma Enter Commercial Licensing Arrangement Covering Captisol-Enabled Programs
Aug 14, 2014 08:00 AM Ligand Signs Multi-Program Captisol® License Agreement with Avion Pharmaceuticals
Aug 13, 2014 08:28 AM Form 8-K LIGAND PHARMACEUTICALS For: Aug 12
Aug 13, 2014 08:08 AM Ligand Pharma (LGND) Prices $225M in Conv. Senior Notes; to Buyback ~700K Shares
Aug 13, 2014 08:00 AM Ligand Prices Offering of $225 Million of Convertible Senior Notes
Aug 12, 2014 07:35 AM Marinus Pharma (MRNS) Enters Agreement for Use of Captisol (LGND)
Aug 11, 2014 05:04 PM Form 8-K LIGAND PHARMACEUTICALS For: Aug 11
Aug 11, 2014 04:03 PM Ligand Pharma (LGND) Announces $225M Convetible Notes Offering; Approves $200M Buyback
Aug 11, 2014 04:01 PM Ligand Announces Proposed Offering of $225 Million of Convertible Senior Notes and Announces $200 Million Share Repurchase Program
Aug 5, 2014 05:22 PM Form 10-Q LIGAND PHARMACEUTICALS For: Jun 30
Aug 4, 2014 02:49 PM Lemelson Increases Short Bet on Ligand Pharma (LGND)
Aug 4, 2014 02:46 PM Lemelson Capital Management Further Increases Short Position in Ligand Pharmaceuticals (NASDAQ: LGND), Updates LGND Research Report with New Material Information
Aug 4, 2014 02:24 PM Roth Still Positive on Ligand (LGND) Following Q2 Results, ASPIRE Phase 3 Update (AMGN)
Aug 4, 2014 09:32 AM Pre-Open Stock Movers 8/4: (PIKE) (TKMR) (LJPC) Higher; (INSM) (ZGNX) (HK) Lower (more...)
Aug 4, 2014 08:40 AM Ligand Pharmaceuticals, Inc. (LGND) Tops Q2 EPS by 10c; Boosts FY14 Outlook
Aug 4, 2014 08:33 AM Form 8-K LIGAND PHARMACEUTICALS For: Aug 04
Aug 4, 2014 08:30 AM Ligand Reports Second Quarter 2014 Financial Results
Aug 1, 2014 02:35 PM Trading Radar for 08/04: Tenet Health (THC), GT Advanced Tech (GTAT), Broadsoft (BSFT), Avis Budget (CAR), Alleghany (Y) Report
Jul 23, 2014 09:30 AM Ligand Partner GSK Announces Record Quarterly Promacta™/Revolade™ Revenue of $92 Million
Jul 23, 2014 08:57 AM Ligand (LGND) Pressure on GSK's Promacta Data is Overreaction - Roth Capital
Jul 22, 2014 01:16 PM SAGE Therapeutics Receives Fast Track Designation for Captisol-enabled SAGE-547 (LGND)
Jul 22, 2014 01:15 PM Ligand Partner SAGE Therapeutics Receives Fast Track Designation for Captisol-enabled SAGE-547 to Treat Status Epilepticus
Jul 22, 2014 10:07 AM Roth Capital Comments on Ligand (LGND) Following SAGE-547 Update
Jul 18, 2014 07:54 AM Roth Capital Sees Prelim. Q2 Revenue Numbers from Ligand (LGND) as Just the Beginning of More Success to Come
Jul 17, 2014 11:53 AM Lemelson Capital Management Announces TTM and Second Quarter 2014 Performance Results for The Amvona Fund
Jul 17, 2014 08:06 AM Form 8-K LIGAND PHARMACEUTICALS For: Jul 17
Jul 17, 2014 08:03 AM Ligand Pharma (LGND) Prelim. Q2 Revs Top Views; Approves $10M Buyback
Jul 17, 2014 08:00 AM Ligand Reports Second Quarter Revenues and Announces Share Repurchase Program
Jul 14, 2014 08:30 AM Ligand Chairman Dr. John W. Kozarich Named Director of the Year Honoree by Corporate Directors Forum
Jul 7, 2014 09:00 AM Lemelson Capital Management Further Increases Short Position in Ligand Pharmaceuticals (NASDAQ: LGND), Appends its LGND Research Report
Jul 1, 2014 12:17 PM Form 4 LIGAND PHARMACEUTICALS For: Jun 30 Filed by: Berkman Charles S
Jul 1, 2014 12:17 PM Form 4 LIGAND PHARMACEUTICALS For: Jun 30 Filed by: Herman Melanie J
Jul 1, 2014 12:16 PM Form 4 LIGAND PHARMACEUTICALS For: Jun 30 Filed by: FOEHR MATTHEW W
Jun 25, 2014 03:42 PM Roth Capital Keeps LIgand Pharma (LGND) at Buy; Glaxo Initiates Promacta Phase III

Back to LGND Stock Lookup